CAPN10
Calpain-10
Also known as: CAN10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HC96
- Gene
- CAPN10
- Ensembl
- ENSG00000142330
- Chromosome
- 2
- Canonical length
- 672 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
672 residues, UniProt reviewed canonical sequence.
>Q9HC96|CAPN10
1 MRAGRGATPA RELFRDAAFP AADSSLFCDL STPLAQFRED ITWRRPQEIC ATPRLFPDDP
61 REGQVKQGLL GDCWFLCACA ALQKSRHLLD QVIPPGQPSW ADQEYRGSFT CRIWQFGRWV
121 EVTTDDRLPC LAGRLCFSRC QREDVFWLPL LEKVYAKVHG SYEHLWAGQV ADALVDLTGG
181 LAERWNLKGV AGSGGQQDRP GRWEHRTCRQ LLHLKDQCLI SCCVLSPRAG ARELGEFHAF
241 IVSDLRELQG QAGQCILLLR IQNPWGRRCW QGLWREGGEG WSQVDAAVAS ELLSQLQEGE
301 FWVEEEEFLR EFDELTVGYP VTEAGHLQSL YTERLLCHTR ALPGAWVKGQ SAGGCRNNSG
361 FPSNPKFWLR VSEPSEVYIA VLQRSRLHAA DWAGRARALV GDSHTSWSPA SIPGKHYQAV
421 GLHLWKVEKR RVNLPRVLSM PPVAGTACHA YDREVHLRCE LSPGYYLAVP STFLKDAPGE
481 FLLRVFSTGR VSLSAIRAVA KNTTPGAALP AGEWGTVQLR GSWRVGQTAG GSRNFASYPT
541 NPCFPFSVPE GPGPRCVRIT LHQHCRPSDT EFHPIGFHIF QVPEGGRSQD APPLLLQEPL
601 LSCVPHRYAQ EVSRLCLLPA GTYKVVPSTY LPDTEGAFTV TIATRIDRPS IHSQEMLGQF
661 LQEVSIMAVM KTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAPN10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- spleen: 29 nTPM
- hippocampal formation: 25 nTPM
- cerebellum: 25 nTPM
- heart muscle: 24 nTPM
- kidney: 23 nTPM
- cerebral cortex: 22 nTPM
Single-cell type
- retinal horizontal cells: 44 nCPM
- esophageal apical cells: 26 nCPM
- endometrial glandular cells: 24 nCPM
- endometrial ciliated cells: 21 nCPM
- astrocytes: 19 nCPM
- pdcs: 17 nCPM
Immune cell
- NK-cell: 2.7 nTPM
- eosinophil: 1.4 nTPM
- T-reg: 1.2 nTPM
- basophil: 1.1 nTPM
- neutrophil: 1.1 nTPM
- gdT-cell: 1 nTPM
Brain region
- cerebellum: 40 nTPM
- hippocampal formation: 35 nTPM
- cerebral cortex: 33 nTPM
- amygdala: 32 nTPM
- thalamus: 32 nTPM
- choroid plexus: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAPN10.
Disease | AllUniProt
Conditions CAPN10 is implicated in, by any mechanism.
- Type 2 diabetes mellitus 1 (T2D1) MIM:601283
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 197 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Inborn genetic diseases
- CAPN10-related disorder
- Diabetes mellitus, noninsulin-dependent, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular component disassembly involved in execution phase of apoptosis
- cellular response to insulin stimulus
- positive regulation of D-glucose import
- positive regulation of insulin secretion
- positive regulation of type B pancreatic cell apoptotic process
- proteolysis
- regulation of actin cytoskeleton organization
- type B pancreatic cell apoptotic process
- vesicle-mediated transport to the plasma membrane
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine peptidase, cysteine active site
- Peptidase C2, calpain, catalytic domain
- Peptidase C2, calpain, large subunit, domain III
- Peptidase C2, calpain, domain III
- Peptidase C2, calpain family
- Calpain subdomain III
- Calpain large subunit, domain III superfamily
- Papain-like cysteine peptidase superfamily
- Calpain family cysteine protease
- Calpain large subunit, domain III
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAPN10 as an antibody target. Whether an autoantibody or antibody against CAPN10 could matter depends on whether native CAPN10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAPN10 is annotated at the cell surface, where native CAPN10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CAPN10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...